InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Thornberry Nancy, Director. Director active across 1 companies, notably Denali Therapeutics Inc.. In total, 3 disclosures have been recorded. The latest transaction was filed on 2 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
05,986 shares0
Common Stock
SEC:0001714899-22-000091:0·
0627 shares0
Common Stock
SEC:0001714899-22-000015·
0627 shares0
Common Stock
SEC:0001714899-22-000015:0·
3 of 3 declarations
About Thornberry Nancy
Nancy Thornberry is a Director at Denali Therapeutics Inc. She contributes to the strategy and governance of the company, bringing her experience in biotechnology. Her role is crucial for the development and implementation of strategic initiatives.
